May 28, 2026 · Form 4 insider transaction
Madryn Asset Management, LP bought 2,071 shares of Neuronetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 20 days after the transaction.
Represents restricted stock units ("RSU") awarded to Avinash Amin as director compensation. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Pursuant to the partnership agreements of each of Madryn Health Partners II, LP ("Health Partners"), Madryn Health Partners II (Cayman Master), LP ("Cayman Master") and Madryn Select Opportunities, LP ("Select Opportunities" and, together with Health Partners and Cayman Master, the "Madryn Funds"), Avinash Amin is deemed to hold the RSU for the benefit of the Madryn Funds, who are entitled to the shares of common stock underlying the RSUs upon vesting.; Represents shares of common stock held by Health Partners, for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor.; Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Cayman Master, and Madryn Health Advisors GP II, LLC, as general partner of Health Advisors, may be deemed to beneficially own the shares held directly by Health Partners and Cayman Master.; Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest.